ÂÜÀòÂÒÂ×

Dustin Carver, MBA, has a diverse range of work experience. Dustin is currently working as the Senior Director of Market Access and Payer Strategy at Recordati Rare Diseases. Prior to this, they were the Head of US Market Access at MindMaze from 2022 to 2023.

Carver spent a significant portion of their career at Novo Nordisk, where they held various roles from 2013 to 2022. Their positions included Director of Market Access Customer Innovation, Associate Director of Market Access Innovation, Senior Manager of Portfolio Contracting & Innovation, Manager of Market Access Pricing Analytics & Value Communication, Associate Manager of Market Intelligence, and Senior Analyst of Strategic Pricing Insights.

Before joining Novo Nordisk, Carver worked as a Senior Analyst of Portfolio Management at Sandoz from 2012 to 2013. Dustin was responsible for identifying candidates for the generic drug portfolio, maintaining competitive intelligence, providing ad-hoc analytics, and developing product strategies.

Carver began their career at Ortho Clinical Diagnostics, where they participated in the JNJ QA/O-LDP Rotational Program from 2005 to 2011. Dustin held roles as a Product Support Scientist, Quality Engineer, and Quality Assurance Scientist. Dustin also worked as an IT Strategic Sourcing Analyst at Johnson & Johnson in 2011 and as a Summer Biotech Fellow at Rutgers University in 2004.

Overall, Carver's work experience showcases their expertise in market access, payer strategy, customer innovation, portfolio management, pricing analytics, and strategic insights.

Dustin Carver, MBA, has a diverse education history. Dustin obtained a Bachelor of Science degree in Biotechnology from Rutgers University in 2005. In 2010, they completed their MBA in Entrepreneurship and Finance from Rutgers Business School. More recently, from 2016 to 2020, they pursued their MSJ in Intellectual Property Law from Seton Hall University School of Law. Additionally, Dustin holds a Six Sigma Green Belt Certification from Johnson & Johnson.